Related Experiment Video
Updated: Feb 22, 2026

04:20
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
637
An infant with prolonged circumcision bleeding and unexplained coagulopathy.
Ali Bay1, Ozlem Karaoglu, Ercan Sivasli
1Division of Pediatric Hematology, Department of Pediatrics, Gaziantep Universitesi Tip Fakultesi Cocuk Hastaliklari Klinigi, Gaziantep University, Gaziantep, Turkey.
Summary
Tyrosinemia type I, a rare genetic disorder, can cause severe bleeding in infants, even without obvious liver failure. Early diagnosis is crucial for managing this coagulopathy.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Tyrosinemia type I is a rare autosomal recessive metabolic disorder.
- Severe liver failure is a common presentation in infants with tyrosinemia type I.
- Coagulation abnormalities are frequent in severe liver disease due to impaired synthesis of clotting factors.
Observation:
- A 4-week-old infant with tyrosinemia presented with significant bleeding post-circumcision.
- The infant showed no other clinical signs indicative of liver failure.
- This case highlights coagulopathy as a potential primary manifestation of hereditary tyrosinemia.
Findings:
- Hereditary tyrosinemia can manifest as a severe coagulopathy.
- The coagulopathy may be present even when overt liver disease is absent.
- The bleeding disorder was unresponsive to standard treatments like vitamin K and fresh frozen plasma.
Implications:
- Tyrosinemia should be considered in the differential diagnosis of unexplained bleeding disorders in infants.
- Prompt recognition is vital, particularly in cases of severe coagulopathy unresponsive to conventional therapies.
- This underscores the importance of considering metabolic disorders in pediatric bleeding cases.
Related Concept Videos
Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Coagulation
11.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K
Extrinsic and Intrinsic Pathways of Hemostasis
13.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K

